REPL logo
REPL NASDAQ US

Replimune Group, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Jul 2018
$8.41
▲ +$0.80 (+10.51%)
Vol 3.2M
3
Quality Score
fail
Mkt Cap
$762.5M
ROE
-82.8%
D/E
27.49
Beta
0.72
52W
$3–$15

Wall Street Consensus

14 analysts · Apr 2026
5
Strong Buy
6
Buy
3
Hold
0
Sell
0
Strong Sell
78.6%
Buy Rating

Price Chart

Earnings

Beat rate: 25.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-0.91 $-0.77 +$0.14
Sep 2025 $-0.80 $-0.90 $-0.10
Jun 2025 $-0.82 $-0.95 $-0.13
Mar 2025 $-0.77 $-0.82 $-0.05

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -69.3% -58.0% -69.3% -69.3% -82.8% -82.8%
P/E (TTM)
Net Margin
Gross Margin
D/E Ratio 21.43 17.29 21.43 21.43 27.49 27.49
Current Ratio 6.94 7.95 6.94 6.94 6.31 6.31

Key Ratios

ROA (TTM)
-61.6%
P/B
1.8
EPS (TTM)
$-3.46
CF/Share
$-3.02
52W High
$14.80
52W Low
$2.68
$2.68 52-Week Range $14.80

How does REPL compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

REPL AAPG ABEO ABOS ABP

REPL valuation vs Biotechnology peers

P/E ratio
0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
1.8
27% below peers (2.5)
vs Peers
vs Industry
Pricier
Div yield
0% below peers (0.0%)
vs Peers
vs Industry
Low yield

REPL profitability vs Biotechnology peers

ROE
-82.8%
23% below peers (-67.3%)
vs Peers
vs Industry
Below avg
Net margin
0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-61.6%
32% below peers (-46.7%)
vs Peers
vs Industry
Weak

REPL financial health vs Biotechnology peers

D/E ratio
27.5
0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
6.3
42% above peers (4.4)
vs Peers
vs Industry
Below avg
Beta
0.7
26% below peers (1.0)
vs Peers
vs Industry
More volatile

REPL fundamentals radar

REPL Peer median Industry

REPL profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

REPL vs peers: key metrics